BlackRock, Inc. (BLK) 13D/13G Filings for TG Therapeutics, Inc. (TGTX)

BlackRock, Inc. 13D and 13G filings for TG Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-10-07
4:08 pm
Purchase		 2024-09-30 13G TG Therapeutics, Inc.
TGTX		 BlackRock Inc.
BLK		 21,956,312
14.200%		 11,188,149increase
(+103.90%)		 Filing
2024-01-26
4:23 pm
Purchase		 2023-12-31 13G TG Therapeutics, Inc.
TGTX		 BlackRock Inc.
BLK		 10,768,163
7.100%		 1,635,273increase
(+17.91%)		 Filing
2023-02-01
4:54 pm
Purchase		 2022-12-31 13G TG Therapeutics, Inc.
TGTX		 BlackRock Inc.
BLK		 9,132,890
6.300%		 230,725increase
(+2.59%)		 Filing
2022-02-01
5:08 pm
Purchase		 2021-12-31 13G TG Therapeutics, Inc.
TGTX		 BlackRock Inc.
BLK		 8,902,165
6.200%		 345,879increase
(+4.04%)		 Filing
2021-02-01
08:30 am
Purchase		 2020-12-31 13G TG Therapeutics, Inc.
TGTX		 BlackRock Inc.
BLK		 8,556,286
6.300%		 2,527,496increase
(+41.92%)		 Filing